Relmex blood glucose testing system - Taiwan Registration b9e6bf488f0f0a57354e23c57250b647
Access comprehensive regulatory information for Relmex blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b9e6bf488f0f0a57354e23c57250b647 and manufactured by Aksotek Company. The authorized representative in Taiwan is Aksotek Company.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Aksotek Company, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
b9e6bf488f0f0a57354e23c57250b647
DHY00500271609
Product Details
It is suitable for in vitro diagnostic use, as a monitoring of blood sugar, it can provide diabetic patients to self-detect fingertip microvascular blood glucose value, or provide professionals to detect venous or arterial whole blood and neonatal microvascular blood glucose value.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Domestic
Dates and Status
Dec 01, 2008
Nov 18, 2020
Apr 14, 2021
Cancellation Information
Logged out
่ช่ซ่จป้ท